XERS News and Press, Xeris Pharmaceuticals Inc. From 12/19/21

Xeris Pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights transaction. The combined company is now called Xeris Biopharma Holdings. Recorlev is ready for approval in Endogenous Cushing’s Syndrome. The FDA set the PDUFA date for January 1s...

Xeris Biopharma (NASDAQ:XERS) announces that its commercialization partner, Tetris Pharma has launched Ogluo (glucagon injection) in the U.K. and it is now available by prescription for the treatment of severe hypoglycemia in in pediatric and adult patients aged 2 years and above with di...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today announced that its commercialization partner, Tetris Pharma (Tetris), has launched ...

Are These Low Priced Penny Stocks On Your Watch List? We’re almost to the halfway point of December, which means the countdown has officially begun. Penny stocks are still at the top mind for many retail traders. Best known for being shares of companies trading below $5 per s...

DURHAM, N.C., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc . (the “Company”), a leader in the field of developing inhaled therapies to treat severe respiratory and chronic diseases, today announced the appointment of Barry Deutsch as chief financial offi...

Progenity PROG +20% amid social media buzz Canoo (NASDAQ:GOEV) +17%. Camber Energy (NYSE:CEI) +17%. Asia Pacific Wire & Cable APWC +14% on 1H results SPI Energy (NASDAQ:SPI) +13%. Ensysce Biosciences (NASDAQ:ENSC) +11%. Mullen Automotive (NASDAQ:MULN) +10%. Vir Biotechnolog...

If you’re looking for penny stocks to buy right now, I’m sure you’ve looked at some of the hot trends in the stock market today. We’ve discussed plenty of them in November too. Whether it’s the latest round of short squeeze penny stocks, meme stocks, popul...

Creative Realities (NASDAQ:CREX) +91% industry merger creates powerful new digital signage leader EyePoint Pharmaceuticals EYPT +36% reports positive EYP-1901 data for treatment of wet AMD Bit Brother (NASDAQ:BTB) +20%. Oxbridge Re Holdings OXBR +15% on Q3 earnings. Cue Biophar...

Xeris Biopharma Holdings, Inc. (XERS) Q3 2021 Earnings Conference Call November 10, 2021 8:30 AM ET Company Participants Allison Wey - Senior Vice President, Investor Relations and Corporate Communications Paul Edick - Chairman and Chief Executive Officer Steve Pieper - Chief Financial Office...

Xeris Pharmaceuticals (NASDAQ:XERS): Q3 GAAP EPS of -$0.39. Revenue of $11.03M (+17.3% Y/Y) in-line. Shares +1.02% PM. Press Release As of September 30, 2021, Xeris reported total cash, cash equivalents, and investments of $93.0 million, compared to $133.8 million at December 31, 2020. For ...